Exceptional Response to Single-Agent Anti-PD1 Therapy Observed in Patients with Advanced Desmoplastic Melanoma By Ogkologos - September 4, 2025 652 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SWOG S1512 study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Trial Establishes Preferred Treatment for Some People with Esophageal Cancer July 9, 2024 Supplemental Breast Cancer Imaging Techniques Could Lead to Earlier Detection of... May 28, 2025 EMA Recommends Extension of Indications for Serplulimab April 22, 2026 Medicare Advantage Plans: Read the Fine Print November 16, 2020 Load more HOT NEWS “My First Thought Was My Children:” Young Mom Diagnosed With Triple-Negative... Women Experience More Side Effects from Pelvic Radiation than Realized Atlantic rowing trio smash world record and raise thousands for cancer... Intratumoural Administration of the Oncolytic Herpes Virus Shows Survival Benefit and...
